Robert I. Blum, President & CEO at CYTOKINETICS INC (CYTK), sold 106,776 shares at $73.44 ($7.3M) on 2026-09-14, disclosed to the SEC on 2026-09-15.
Scheduled sale ($7.3M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,350 | $0 | 0.0% |
| 2 | $73.44 | 7,500 | $551K | 7.5% |
| 3 | $69.33 | 97,926 | $6.8M | 92.5% |
| Total | $68.74 avg | 106,776 | $7.3M | 100% |
| Filing → |
| CYTK | SELL | 2026-08-31 | $527K | — | Filing → |
| CYTK | SELL | 2026-08-10 | $576K | — | Filing → |
| CYTK | SELL | 2026-07-27 | $607K | — | Filing → |